Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.03. | Recce Pharmaceuticals - R&D advance (A$11.18m) extends runway | 168 | Edison Investment Research | Recce Pharmaceuticals recently received A$11.18m as an R&D advance credit through an arrangement with Endpoints Capital for the R&D tax credit rebates that Recce expects to receive for FY23/FY24 and... ► Artikel lesen | |
26.03. | Immix Biopharma - Marching towards US clinical trials for NXC-201 | 310 | Edison Investment Research | Immix Biopharma is closer to dosing its first US patient for lead CAR-T asset NXC-201, with the appointment of the Memorial Sloan Kettering Cancer Center as the main clinical site for the company's... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 3.911 |
EVOTEC | 3.135 |
TUI | 2.763 |
NVIDIA | 2.670 |
BAYER | 2.631 |
NEL | 2.402 |
RENK GROUP | 1.765 |
RHEINMETALL | 1.675 |
TESLA | 1.273 |
PALANTIR TECHNOLOGIES | 1.243 |
VOLKSWAGEN | 1.238 |
DEUTSCHE BANK | 1.128 |
PLUG POWER | 1.047 |
MICROSTRATEGY | 1.029 |
BYD | 1.025 |
AMAZON | 1.019 |
BASF | 1.007 |
COMMERZBANK | 1.007 |
PROSIEBENSAT.1 | 1.006 |
MERCEDES-BENZ | 929 |
THYSSENKRUPP | 924 |
ALLIANZ | 871 |
JINKOSOLAR | 868 |
DEUTSCHE TELEKOM | 861 |
AIXTRON SE | 858 |